Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| INDEX NAME NOT YET ASSIGNED | C16H13BrN6O2 | 2749405-42-1 | Details |
| Imatinib Impurity 11 | C24H20ClN5O | 404844-11-7 | Details |
| 3-(4-fluorophenyl)-3-oxopropanamide | C9H8FNO2 | 671188-82-2 | Details |
| 4-Chlorobenzoylacetonitrile | C9H6ClNO | 4640-66-8 | Details |
| Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl- | C23H31N3 | 132810-75-4 | Details |
| Linagliptin Impurity S | C30H36N8O4 | 668273-74-3 | Details |
| Mometasone | C22H28Cl2O4 | 105102-22-5 | Details |
| Diethyl 2-(2-chloroethyl)propanedioate | C9H15ClO4 | 18719-42-1 | Details |
| 6-Chloro-1H-cinnolin-4-one | C8H5ClN2O | 876-89-1 | Details |
| Cycloocta[b]pyridine, 2-chloro-4-(3-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H17ClFN | 132813-15-1 | Details |
| 2-Chloro-4-(4-fluorophenyl)-5，6，7，8，9，10-hexahydrocycloocta[b]pyridine | C17H17ClFN | 132813-14-0 | Details |
| Cabozantinib impurity 51 | C10H10FNO | 2354-89-4 | Details |
| Blonanserin Impurity I | C7H16N2 | 49860-76-6 | Details |
| Cabozantinib Impurity4 | C11H15NO3 | 95932-39-1 | Details |
| Cabozantinib impurity 47 | C11H10ClNO3 | 113136-79-1 | Details |
| Cabozantinib Impurity 8 | C11H10FNO3 | 918642-61-2 | Details |
| Cabozantinib Impurity 6 | C28H24FN3O6 | 1621681-63-7 | Details |
| Cabozantinib Impurity 10 | C39H34N4O8 | 2439164-91-5 | Details |
| tert-butyl (R)-(1-((4-methylquinazolin-2-yl)methyl)piperidin-3-yl)carbamate | C20H28N4O2 | 2514949-81-4 | Details |
| Cycloocta[b]pyridin-2-amine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H19FN2 | 2518376-10-6 | Details |
| Formamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]- | C18H16N2O4 | 190728-28-0 | Details |
| 1-(phenylaminocarbonyl)cyclopropanecarboxylicacid | C11H11NO3 | 145591-80-6 | Details |
| Linagliptin Impurity 24 | C50H56N16O4 | 1418133-47-7 | Details |
| Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)- | C17H14N2O5 | 190728-24-6 | Details |
| Cycloocta[b]pyridine, 4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)- | C21H26FN3 | 132811-84-8 | Details |
| Linagliptin Impurity 16 | C15H20N6O2 | 1791405-13-4 | Details |
| N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-phenylcyclopropane-1,1-dicarboxamide | C28H25N3O5 | 849221-94-9 | Details |
| 1,1-Cyclobutanedicarboxylic acid | C6H8O4 | 5445-51-2 | Details |
| Blonanserin Impurity K | C23H30FN3O | 142838-82-2 | Details |
| 4-(4-Carboxybenzyl)piperazine-1-carboxylic acid tert-butyl ester | C17H24N2O4 | 479353-63-4 | Details |
| Linagliptin Impurity 29 | C58H58N16O6 | 2074688-82-5 | Details |
| Imatinib EP Impurity F | C16H15N5 | 152460-10-1 | Details |
| 3-Dimethylamino-1-(N-oxido-4-pyridyl)-2-propen-1-on | C10H12N2O2 | 2387475-37-6 | Details |
| Linagliptin Impurity 35 | C30H36N8O4 | 668273-75-4 | Details |
| 2-(4-ethylpiperazin-1-yl)-4-(4-(4-ethylpiperazin-1-yl)phenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine | C29H43N5 | 1648791-23-4 | Details |
| Cabozantinib Impurity 14 | C12H13NO3 | 1175127-32-8 | Details |
| Blonanserin Impurity 18 | C19H24FN3 | 1477480-40-2 | Details |
| 2-Propenenitrile, 3-amino-3-(3-fluorophenyl)- | C9H7FN2 | 71682-85-4 | Details |
| N-Desmethyl Imatinib | C28H29N7O | 404844-02-6 | Details |
| 1,4-Bis-[4-[4-Methyl-3-[[4-(pyridin-3-yl)pyriMidin-2-yl]aMino]phenyl]carbaMoyl]benzylpiperazine | C52H48N12O2 | 1365802-18-1 | Details |
| Blonanserin iMpurity | C23H30FN3 | 132810-83-4 | Details |
| Desfluoro Hydroxy Blonanserin | C23H31N3O | 132812-29-4 | Details |
| 1-((4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)carbamoyl)cyclopropane-1-carboxylic acid | C22H20N2O6 | 849217-77-2 | Details |
| 3-(2-Fluorophenyl)-3-oxopropionitrile | C9H6FNO | 31915-26-1 | Details |
| 3-Amino-3-(4-chlorophenyl)prop-2-enenitrile | C9H7ClN2 | 25354-58-9 | Details |
| Imatinib Impurity 19 | C7H7NO2 | 14188-94-4 | Details |
| Diazene, bis(4-fluorophenyl)-, (Z)- (9CI) | C12H8F2N2 | 51789-00-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C26H32N8O4 | 2748381-67-9 | Details |
| 1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylicacid | C11H10FNO3 | 849217-48-7 | Details |
| 4-((6,7-Dimethoxyquinolin-4-yl)oxy)aniline | C17H16N2O3 | 190728-25-7 | Details |
| Cabozantinib Impurity 42 | C9H8FNO3 | 95262-10-5 | Details |
| Cabozantinib Impurity 9 | C17H14F2N2O2 | 1431468-36-8 | Details |
| 2-chloro-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine 1-oxide | C17H17ClFNO | 143213-96-1 | Details |
| Imatinib EP Impurity C | C21H26ClN2O4+ | 1407124-77-9 | Details |
| Imatinib EP Impurity J | C29H31N7O2 | 571186-91-9 | Details |
| iMatinib related substance B | C29H31N7O3 | 571186-93-1 | Details |
| Mometasone Furoate Impurity O | C24H31ClO6 | 24916-91-4 | Details |
| (Z)-3-Amino-3-(4-fluoro-phenyl)-acrylonitrile | C9H7FN2 | 55330-46-6 | Details |
| Imatinib Impurity 17 | C20H22N2O4 | 1802325-93-4 | Details |
| 6,7-Quinolinediol, 4-chloro- | C9H6ClNO2 | 1256637-72-5 | Details |
| Cyclobutanecarboxylic acid, 1-[[(4-fluorophenyl)amino]carbonyl]- | C12H12FNO3 | 849217-49-8 | Details |
| Cycloocta[b]pyridine, 2-chloro-4-(4-chlorophenyl)-5,6,7,8,9,10-hexahydro- | C17H17Cl2N | 132813-22-0 | Details |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | C20H17BrN6O2 | 853029-57-9 | Details |
| Linagliptin iMpurity G | C25H28N8O2 | 668270-11-9 | Details |
| Blonanserin Impurity 10 | C23H30ClN3 | 132810-87-8 | Details |
| 3-Fluorobenzoylacetonitrile | C9H6FNO | 21667-61-8 | Details |
| Cabozantinib Impurity 11 | C18H18N2O2 | 861345-47-3 | Details |
| N-Depiperidin-3-amine Linagliptin Dimer | C45H44N14O4 | 2253964-98-4 | Details |
| 3-amino-3-(4-fluorophenyl)propanenitrile | C9H9FN2 | 1270488-91-9 | Details |
| 4-Fluorobenzoylacetonitrile | C9H6FNO | 4640-67-9 | Details |
| 2-amino-6-methylbenzenecarboximidamide | C8H11N3 | 1694987-11-5 | Details |
| 2 - (ChloracetylaMino)acetophenon | C10H10ClNO2 | 6140-11-0 | Details |
| Cabozantinib impurity 1 | C17H16N2O3 | 748707-58-6 | Details |
| 4-[(E)-(4-hydroxyphenyl)azo]phenol | C12H10N2O2 | 51437-66-2 | Details |
| Cabozantinib Impurity 25 | C11H10FNO3 | 1247859-37-5 | Details |
| Linagliptin Impurity A | C14H13BrN4O2 | 2436762-89-7 | Details |
| Linagliptin Impurity 45 | C25H28N8O2 | 2463617-43-6 | Details |
| N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide(CabozantinibImpurity) | C17H15FN2O3 | 849217-60-3 | Details |
| Benzenepropanoic acid, 4-fluoro-b-oxo- | C9H7FO3 | 80646-00-0 | Details |
| iMatinib related substance C | C29H31N7O2 | 938082-57-6 | Details |
| 11,17-Difuroate MoMetasone Furoate | C32H32Cl2O8 | 1370190-33-2 | Details |
| Linagliptin Impurity 28 | C22H23N7O3 | 2074688-84-7 | Details |
| Cabozantinib Impurity 5 | C11H10ClNO3 | 2377278-36-7 | Details |
| 6-Chloro-1-hydroxibenzotriazol | C6H4ClN3O | 26198-19-6 | Details |
| Linagliptin impurity KH-2 | C20H18BrN5O4 | 2279114-31-5 | Details |
| Benzoic acid, 4,4'-[1,4-piperazinediylbis(methylene)]bis-, dimethyl ester (9CI) | C22H26N2O4 | 80276-39-7 | Details |
| Acetamide, N-(2-acetylphenyl)-2,2-dichloro- | C10H9Cl2NO2 | 6140-12-1 | Details |
| 3-AMINO-3-(4-BROMOPHENYL)ACRYLONITRILE | C9H7BrN2 | 748807-82-1 | Details |
| 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-[(4-methyl-2-quinazolinyl)methoxy]-1-[(4-methyl-2-quinazolinyl)methyl]- | C30H26N8O3 | 2469626-53-5 | Details |
| Cycloocta[b]pyridin-2(1H)-one, 5,6,7,8,9,10-hexahydro-4-phenyl- | C17H19NO | 132812-71-6 | Details |
| Tert-butyl4-(4-(methoxycarbonyl)benzyl)piperazine-1-carboxylate | C18H26N2O4 | 844891-11-8 | Details |
| (E)-3-AMINO-3-(4-CHLOROPHENYL)-2-PROPENENITRILE;(2E)-3-amino-3-(4-chlorophenyl)prop-2-enenitrile | C9H7ClN2 | 107840-43-7 | Details |
| Cycloocta[b]pyridin-2(1H)-one, 4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydro- | C17H18FNO | 132812-74-9 | Details |
| Blonanserin Impurity 15 | C17H17ClFN | 132813-16-2 | Details |
| 1-Piperazinecarboxaldehyde, 4-ethyl- | C7H14N2O | 21863-75-2 | Details |
| N1,N3-bis(4-fluorophenyl)malonamide(CabozantinibImpurity） | C15H12F2N2O2 | 1677-29-8 | Details |
| Ethanone, 1,1'-cyclobutylidenebis- | C8H12O2 | 126290-88-8 | Details |
| Cabozantinib impurity | C17H14Cl2N2O2 | 1904529-45-8 | Details |
| N1-ethyl-N2-(4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridin-2-yl)ethane-1,2-diamine hydrochloride | C21H28FN3 | 2243798-59-4 | Details |
| Benzamide, 4-[[4-[4-[(4-methyl-1-piperazinyl)methyl]benzoyl]-1-piperazinyl]methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- | C41H45N9O2 | 2410195-23-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 | ||||